The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 32.70
High: 32.70
Low: 32.70
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

nDreams appoints new Non-executive Chair

4 Aug 2021 07:00

RNS Number : 4719H
Mercia Asset Management PLC
04 August 2021
 

RNS

4 August 2021

 

Mercia Asset Management PLC

 

("Mercia", "the Group" or the "Company")

 

nDreams appoints new Non-executive Chair

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£940million of assets under management, is pleased to note the appointment of Frank Sagnier as Non-executive Chair of portfolio company nDreams Limited ("nDreams").

 

Frank Sagnier's career in the video games industry spans more than 25 years, having most recently retired from Codemasters Group Holdings plc ("Codemasters") following its acquisition by Electronic Arts Inc. ("EA") for c.$1.2billion. He joined the games developer and publisher in 2014 as Chief Executive Officer and was instrumental in its successful AIM IPO, growth and subsequent sale to EA.

 

nDreams is a leading developer and publisher of virtual reality ("VR") games including Phantom: Covert Ops for Oculus headsets and the highly anticipated Fracked for PlayStation VR, that will be launched globally on 20th August 2021. nDreams has also collaborated with Ubisoft and Zero Latency VR on development of the free-roam arcade experience Far Cry VR: Dive into Insanity, that can be experienced worldwide at Zero Latency venues. Further developments include nDreams' move into third-party publishing and the recent announcement of a second fully remote studio, nDreams Studio Orbital, which will focus on developing live service games for VR. Mercia holds a 35.4% fully diluted direct investment stake with a further 4.0% fully diluted stake held by Mercia's managed funds. 

 

Frank Sagnier, Non-executive Chair of nDreams, said: "I am delighted to join nDreams' board to help the company achieve its mission to become a world-leading developer and publisher of VR games. Over the past few years, Patrick has built a reputable studio with highly-talented teams delivering high-quality games. The fast-improving hardware together with immersive and innovative player experiences, means that the VR market is bound to see significant growth and exciting times ahead."

 

Patrick O'Luanaigh, CEO and founder of nDreams, said: "I'm delighted to welcome Frank to nDreams' board. I've known Frank since he was building up EA Partners and I am certain that his experience, passion and drive will push us forward as we head towards some very ambitious goals. Frank's energy and wisdom will be significant assets, and the management team and I are excited to work with him."

 

Julian Viggars, Chief Investment Officer of Mercia, said: "As Mercia's representative on the board of nDreams, I am increasingly excited about the growing appetite for VR technology, alongside the broader momentum being seen in the video games industry. nDreams has seen its revenue grow by 30% this financial year and has a number of titles under development, plus a strong pipeline of future projects. Patrick and his team have built one of the leading VR studios and Frank is the ideal chair to help guide nDreams through its ambitious next phase. His games industry experience and track record makes him best placed to support Patrick and the team to continue to drive growth and deliver on their strategic objectives, whilst maintaining nDreams' reputation for content quality and delivery."

 

-Ends-

 

For further information, please contact:

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

N+1 Singer (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

+44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Shiv Talwar

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£940million of assets under management and, since its IPO in December 2014, has invested c.£111million gross into its direct investment portfolio.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

About nDreams

nDreams Ltd. (www.ndreams.com) is an award-winning virtual reality developer and publisher, with a proven track record in creating commercially successful and memorable experiences for leading VR platforms, including the award-winning Phantom: Covert Ops. nDreams is an approved developer partner with Sony PlayStation, Oculus, HTC, Microsoft HoloLens, Google and Samsung.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPJMRTMTMMBRB
Date   Source Headline
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update
25th Mar 20201:42 pmRNSNotification of Major Holdings
18th Mar 202010:59 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20204:18 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSPDMR / Director Dealings
4th Feb 20208:50 amRNSNotification of Major Holdings
4th Feb 20207:00 amRNSHolding in Company
29th Jan 20207:00 amRNSGrant of Options
22nd Jan 202012:49 pmRNSForm 8.3 - RedX Pharma PLC
17th Jan 20204:45 pmRNSNotification of Major Holdings
16th Jan 20207:00 amRNSnDreams makes continuing commercial progress
9th Jan 20202:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jan 20202:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Dec 201910:55 amRNSNotification of Major Holdings
30th Dec 201911:57 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Dec 201911:36 amRNSNOTIFICATION OF MAJOR HOLDINGS
27th Dec 201912:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
24th Dec 201912:16 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20193:36 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:14 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:04 pmRNSCompletion of Acquisition
23rd Dec 201912:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20199:49 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.